BRAIN Biotech AG

BRAIN Biotech AG takes next step to optimize group structure

Beverages made from vine leaves: Sustainable drinking pleasure based on agricultural side streams

Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG

Collaboration between BRAIN Biotech and AMSilk: Protein engineering successfully improves structural proteins for performance materials

BRAIN Biotech AG successfully placed EUR 5.0 million convertible bond for the financing of further growth initiatives

BRAIN Biotech AG: Issuance of EUR 5 million convertible bond with exclusion of subscription rights